Coincidentally I've just read a very recent RCT published in JAMA about the exact question of transplantation in intermediate-risk AML.
https://jamanetwork.com/journals/jamaoncology/article-abstract/2801295?guestAccessKey=ff239124-36f9-4afb-92c0-fe4e323cfcde&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology…
Coincidentally I've just read a very recent RCT published in JAMA about the exact question of transplantation in intermediate-risk AML.
https://jamanetwork.com/journals/jamaoncology/article-abstract/2801295?guestAccessKey=ff239124-36f9-4afb-92c0-fe4e323cfcde&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology&utm_content=olf&utm_term=020923
It seems it has a worse mortality trend. Thoughts?